Gritstone Oncology Inc (GRTS)

Gritstone Oncology (GRTS) Stock Price & Analysis


GRTS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.14 - $4.05
Previous Close$1.3
Average Volume (3M)2.43M
Market Cap
Enterprise Value$135.30M
Total Cash (Recent Filing)$83.95M
Total Debt (Recent Filing)$95.30M
Price to Earnings (P/E)-1.0
Mar 07, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.30
Shares Outstanding95,342,055
10 Day Avg. Volume1,326,185
30 Day Avg. Volume2,434,882
Standard Deviation0.52
Financial Highlights & Ratios
Price to Book (P/B)1.70
Price to Sales (P/S)6.21
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue13.23
Enterprise Value/Gross Profit6.78
Enterprise Value/Ebitda-0.99
Price Target Upside579.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6



Ownership Overview

7.83% Mutual Funds
27.38% Other Institutional Investors
64.79% Public Companies and
Individual Investors


What was Gritstone Oncology Inc’s price range in the past 12 months?
Gritstone Oncology Inc lowest stock price was $1.14 and its highest was $4.05 in the past 12 months.
    What is Gritstone Oncology Inc’s market cap?
    Currently, no data Available
    When is Gritstone Oncology Inc’s upcoming earnings report date?
    Gritstone Oncology Inc’s upcoming earnings report date is Mar 07, 2024 which is in 96 days.
      How were Gritstone Oncology Inc’s earnings last quarter?
      Gritstone Oncology Inc released its earnings results on Nov 08, 2023. The company reported -$0.33 earnings per share for the quarter, beating the consensus estimate of -$0.34 by $0.01.
        Is Gritstone Oncology Inc overvalued?
        According to Wall Street analysts Gritstone Oncology Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Gritstone Oncology Inc pay dividends?
          Gritstone Oncology Inc does not currently pay dividends.
          What is Gritstone Oncology Inc’s EPS estimate?
          Gritstone Oncology Inc’s EPS estimate is -$0.29.
            How many shares outstanding does Gritstone Oncology Inc have?
            Gritstone Oncology Inc has 95,342,060 shares outstanding.
              What happened to Gritstone Oncology Inc’s price movement after its last earnings report?
              Gritstone Oncology Inc reported an EPS of -$0.33 in its last earnings report, beating expectations of -$0.34. Following the earnings report the stock price went down -7.692%.
                Which hedge fund is a major shareholder of Gritstone Oncology Inc?
                Among the largest hedge funds holding Gritstone Oncology Inc’s share is Versant Venture Management, LLC. It holds Gritstone Oncology Inc’s shares valued at 6M.


                  Company Description

                  Gritstone Oncology Inc

                  Gritstone Oncology, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded in August 2015 by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria and is headquartered in Emeryville, CA.


                  Top 5 ETFs holding GRTS

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold GRTS. The ETFs are listed according to market value of GRTS within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Adaptimmune Therapeutics
                  Arvinas Holding Company

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis